Polymer coatings over iron oxide |
1 |
Poly (D,L-lactide) |
Enhanced biocompatibility |
Usually very unstable (affected with varying pH and temperature); agglomeration and adherence property (causing toxic and immunogenic effects); inside body system, hydrodynamic flow retards its movement (mostly dissolved in body fluids and degradation due to enzyme activity) |
13, 14
|
2 |
Polyacrylic acid |
Improves bioadhesion |
15, 16
|
3 |
Phosphorylcholine |
Initiates coagulation |
17 |
4 |
Polyvinyl pyrrolidone |
Improves functionalization |
18 |
5 |
Polyvinyl alcohol |
Increases monodisperse particle formation |
19–22
|
6 |
Polyethylene glycol |
Improves biocompatibility |
23, 24
|
7 |
Dextran |
Biocompatible, controlling particle size and shapes |
25, 26
|
8 |
Polystyrene |
Uniform cluster formation, controlling particle size and shapes |
27 |
9 |
Starch |
Biocompatible, coating material |
28, 29
|
10 |
Ethyl cellulose |
Enhances drug uptake, good functional property |
30, 31
|
11 |
Gelatin |
Natural, biocompatible |
32–34
|
12 |
Chitosan |
Natural, biocompatible |
35 |
13 |
Fatty acids |
Terminal group functionalization, biocatalyst |
36, 37
|
14 |
Bovine serum albumin |
Biocompatible |
38 |
15 |
Folic acid |
Targets cancer cells, less immunogenic |
39 |
16 |
Insulin |
Improves gene therapy |
40 |
17 |
Liposome |
Long circulatory time in body system |
41 |
Metal and metal oxide coatings over iron oxide |
1 |
Gold |
Enhances optical properties and stabilization |
Toxic effects, fabrication difficulties, and cost associated with its synthesis |
42, 43
|
2 |
Silver |
Enhances optical properties and antimicrobial activity |
|
44 |
3 |
Platinum |
Enhances optical and electrochemical properties |
|
45 |
4 |
Zinc |
Enhances magnetic property |
|
46 |
5 |
SiO2
|
Increases surface area and binding affinity |
Increases oxidative stress and agglomerates |
47, 48
|
6 |
TiO2
|
Photocatalytic activity |
Nonbiological application only |
49 |
7 |
Calcium phosphate coating |
Biocompatible, osteoconductive |
Difficult to control coating layer thickness |
50 |
8 |
Hydroxyapatite |
Biocompatible, stable, osteoconductive |
Difficult to control coating layer thickness |
65–107
|